DefaultUser

Staff Physician II, Division of Gastroenterology, Hepatology and Nutrition

513-636-4415

Board Certified

About Me

Clinical Interests

Pediatric gastroenterology; non-alcoholic steatohepatitis

Clinical Divisions

Gastroenterology GI, Steatohepatitis

My Locations

  • Anderson

    Anderson

    7495 State Road
    Suite 355
    Cincinnati, Ohio 45255
    1-513-636-6100
    Go

My Education

BS: Stanford University, Stanford, CA, 2000.

MD: University of Cincinnati, Cincinnati, OH, 2006.

Residency: Schneider Children’s Hospital (Renamed Cohen Children’s Medical Center of New York), New Hyde Park, NY, 2009.

Chief Residency: Pediatrics, Schneider Children’s Hospital (Renamed Cohen Children’s Medical Center of New York), New Hyde Park, NY, 2010.

Fellowship: Pediatric Gastroenterology, Cincinnati Children's Hospital Medical Center, 2013.

My Publications

Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. Xanthakos, SA; Lavine, JE; Yates, KP; Schwimmer, JB; Molleston, JP; Rosenthal, P; Murray, KF; Vos, MB; Jain, AK; Scheimann, AO; et al. Gastroenterology. 2020; 159:1731-1751.e10.

Identifying Predictors of Response to Vitamin E for the Treatment of Pediatric Nonalcoholic Steatohepatitis. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Su, W; Fei, L; Xanthakos, SA; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2020; 44:1301-1307.

Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. Yodoshi, T; Orkin, S; Clachar, AA; Bramlage, K; Sun, Q; Fei, L; Beck, AF; Xanthakos, SA; Trout, AT; Mouzaki, M. The Journal of Pediatrics. 2020; 223:93-99.e2.

Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease. Yodoshi, T; Arce-Clachar, AC; Sun, Q; Fei, L; Bramlage, K; Xanthakos, SA; Flores, F; Mouzaki, M. The Journal of Pediatrics. 2020; 222:127-133.

Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Liu, C; Fei, L; El-Khider, F; Dasarathy, S; Xanthakos, SA; Mouzaki, M. European Journal of Clinical Nutrition. 2020; 74:427-435.

Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Brokamp, C; Yodoshi, T; Trout, AT; Liu, C; Meryum, S; Taylor, S; Wolfe, C; Sheridan, R; Seth, A; et al. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70:364-370.

Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease. Seth, A; Orkin, S; Yodoshi, T; Liu, C; Fei, L; Hardy, J; Trout, AT; Arce Clachar, A; Bramlage, K; Xanthakos, S; et al. Pediatric Obesity. 2020; 15.

Psychotropic Medications Are Associated with Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. Mouzaki, M; Yodoshi, T; Arce-Clachar, AC; Bramlage, K; Fei, L; Ley, SL; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2019; 69:339-343.

Extremely low levels of low-density lipoprotein potentially suggestive of familial hypobetalipoproteinemia: A separate phenotype of NAFLD?. Mouzaki, M; Shah, A; Arce-Clachar, AC; Hardy, J; Bramlage, K; Xanthakos, SA. Journal of Clinical Lipidology. 2019; 13:425-431.

Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. Mouzaki, M; Bramlage, K; Arce-Clachar, AC; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2018; 67:631-634.